Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0044350 THERAPEUTIC CYCLIC COMPOUNDS AS IMMUNOMODULATORS
The present invention relates to cyclic compounds of formula (I) and their use to inhibit the programmed cell death 1 (PD-1) signaling pathway and/or for...
2018/0044349 ISOIDIDE MANUFACTURE AND PURIFICATION
Methods are provided for the conversion of isosorbide to isoidide, wherein the isosorbide contains sorbitan impurities. The impurities in the isosorbide...
2018/0044348 CRYSTALLINE SALTS OF MORPHINE SULFATE
Crystalline salts of 7,8-Didehydro-4,5 alpha-epoxy-17-methylmorphinan-3,6 alpha-diol sulfate(2:1), i.e. of morphine sulphate, are disclosed and four...
2018/0044347 CRYSTALLINE SALTS OF HYDROCODONE BITARTRATE
Crystalline salts of 4,5 .alpha.-epoxy-3-methoxy-17-methylmorphinan-6-one tartrate (1:1) (hydrocodone bitartrate) are disclosed and three polymorphic forms of...
2018/0044346 HETEROCYCLIC COMPOUNDS AND USES THEREOF
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods...
2018/0044345 PROCESSES FOR MAKING PONATINIB AND INTERMEDIATES THEREOF
Methods are disclosed for making 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide,...
2018/0044344 CDK2/4/6 Inhibitors
This invention relates to compounds of general Formula (I) ##STR00001## and pharmaceutically acceptable salts thereof, in which R.sup.1, R.sup.2, R.sup.2A,...
2018/0044343 BICYCLIC IMIDAZOLO DERIVATIVE
Disclosed are compounds, having the following structure, useful as inhibitors of Phosphodiesterase 1 (PDE1), compositions comprising the compounds, and methods...
2018/0044342 CRYSTAL FORM OF JAK INHIBITOR AND PREPARATION METHOD THEREOF
The present disclosure relates to novel crystalline forms of JAK inhibitors and the preparation method thereof. The novel crystalline forms in the present...
2018/0044341 4-AMINO-3-PHENYLAMINO-6-PHENYLPYRAZOLO[3,4-D]PYRIMIDINE DERIVATIVES FOR USE AS BCRP INHIBITORS IN THERAPEUTIC...
The present invention relates to 5-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives of the general formula (I) or pharmaceutically acceptable...
2018/0044340 TRIAZOLOTRIAZINONE DERIVATIVES HAVING ACTIVITY A S HERBICIDES
The present invention relates to compounds of Formula (I), or an agronomically acceptable salt of said compounds wherein Q, R.sup.2 and R.sup.3 are as defined...
2018/0044339 PROCESS FOR PREPARING IBRUTINIB
The present application relates to a method for preparing Ibutinib as shown by the following synthetic route and the intermediate compounds involved therein. ...
2018/0044338 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
Provided herein are novel substituted bridged urea and related analogs and methods of use thereof. The sirtuin-modulating compounds may be used for increasing...
2018/0044337 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS
The present invention provides methods for the preparation of substituted heterocycle fused gamma-carbolines, intermediates useful in producing them and...
2018/0044336 CRYSTALLINE FORM OF A JAK3 KINASE INHIBITOR
The invention relates to novel co-crystals of a drug substance and their use to treat respiratory diseases such as asthma and COPD.
2018/0044335 New Pyridinones and Isoquinolinones as Inhibitors of the Bromodomain BRD9
The present invention encompasses compounds of general formula (I) wherein the groups R.sup.1 to R.sup.9, X.sub.1 and X.sub.2 have the meanings given in the...
2018/0044334 HISTONE DEMETHYLASE INHIBITORS
The present disclosure relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyridine...
2018/0044333 Tricyclic Spacer Systems for Nonlinear Optical Devices
A compound for spacing nonlinear optical chromophores of the Formula I ##STR00001## and the commercially acceptable salts, solvates and hydrates thereof, wherein...
2018/0044332 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO
This disclosure relates to the field of molecules having pesticidal utility against pests in phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce...
2018/0044331 PIPERAZINE DERIVATIVES FOR TREATING DISORDERS
Anti-angiogenic treatments, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of...
2018/0044330 PHTHALAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
The invention relates to a compound of Formula I and methods of treating CFTR (cystic fibrosis transmembrane conductance regulator) mediated diseases, in...
2018/0044329 3-SUBSTITUTED-1,2,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS
The present invention relates to 3-substituted-1,2,4-oxadiazole and thiadiazole compounds of formula (I) or formula (II) and their use to inhibit the...
2018/0044328 PEPTIDYL NITRIL COMPOUNDS AS DIPEPTIDYL PEPTIDASE I INHIBITORS
The invention relates to compounds of Formula (I) and their use as selective pharmaceutical compositions comprising said compounds, and methods of treatment...
2018/0044327 COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGRADATION
The present disclosure relates to compounds, compositions, and methods useful for treating retinal damage and/or retinal degradation/retinal degeneration, for...
2018/0044326 LACTAMS AS INHIBITORS OF ROCK
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof wherein all the variables...
2018/0044324 Quinolinones as Inhibitors of Translation Initiation Complex
Provided herein are compounds and pharmaceutical compositions comprising quinolinones. The quinolinones and compositions thereof are useful as eukaryotic...
2018/0044323 DEUTERATED DIAMINOPYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH COMPOUNDS
Deuterated diaminopyrimidine compounds, and intermediates thereof are described. In particular, disclosed are deuterated diaminopyrimidine compounds of formula...
2018/0044322 Novel Heterocyclic Compound, Method for Preparing the Same, and Pharmaceutical Composition Comprising the Same
The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by...
2018/0044321 NOVEL PIPERIDINE CARBOXAMIDE COMPOUND, PREPARATION METHOD, AND USE THEREOF
The present invention provides a compound of a general formula I, a stereomeride, pharmaceutically acceptable salt or a solvate thereof, a preparation method...
2018/0044320 COMPOSITIONS COMPRISING AN INHIBITOR OF LYSINE SPECIFIC DEMETHYLASE-1
Described herein are amorphous and crystalline forms of pharmaceutically acceptable salts of the lysine specific demethylase-1 inhibitor ...
2018/0044319 PROCESSES FOR THE PREPARATION OF PESTICIDAL COMPOUNDS
The present application provides processes for making pesticidal compounds and compounds useful both as pesticides and in the making of pesticidal compounds.
2018/0044318 PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS
The present invention provides new processes for the preparation of unsubstituted and substituted 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione...
2018/0044317 BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS
Compounds of formula (I) and salts thereof: ##STR00001## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 are defined herein. Compounds of formula (I) and salts...
2018/0044316 POTENTIATORS OF BETA-LACTAM ANTIBIOTICS
We disclose herein that the BlaR1 protein of methicillin-resistant Staphylococcus aureus (MRSA), an antibiotic sensor/signal transducer, is phosphorylated on...
2018/0044315 CYCLIC CARBONATE MONOMER CONTAINING DOUBLE IODINE, BIODEGRADABLE POLYMER PREPARED THEREBY AND USE
The disclosure relates to a cyclic carbonate monomer containing double iodine, a biodegradable polymer prepared thereby and use. The polymer can be obtained by...
2018/0044314 METHOD OF TREATING OR PREVENTING RAS-MEDIATED DISEASES
Disclosed are compounds, for example, a compound of formula I, wherein R, R.sub.0, R.sub.1-R.sub.8, n, X, Y, Y', and E are as described herein, pharmaceutical...
2018/0044313 METHOD FOR PRODUCING TETRAHYDROPYRANYL ESTERS
The present invention relates to a method for preparing tetrahydropyranyl esters from the corresponding 4-hydroxytetrahydropyran compounds by reaction with a...
2018/0044312 METHOD FOR MANUFACTURING FURAN-2,5-DICARBOXYLIC ACID (FDCA) FROM A SALT SOLUTION
A method for manufacturing furan-2,5-dicarboxylic acid (FDCA) by converting a furan-2,5-dicarboxylate salt (MFDC) into FDCA, including the steps of combining...
2018/0044311 UTILIZING A MULTIPHASE REACTOR FOR THE CONVERSION OF BIOMASS TO PRODUCE SUBSTITUTED FURANS
The present disclosure provides methods to produce substituted furans (e.g., halomethylfurfural, hydroxymethylfurfural, and furfural), by acid-catalyzed...
2018/0044310 PROCESS FOR THE PREPARATION OF GAMMA VALEROLACTONE FROM LEVULINIC ACID
The invention relates to process for the preparation of gamma valerolactone (GVL) from levulinic acid (LA), said process comprising a) subjecting LA to a...
2018/0044309 EPOXIDATION PROCESS
A method for the oxidation of ethylene to form ethylene oxide which comprises: providing an aqueous stream containing ethylene glycol and impurities;...
2018/0044308 SYSTEMS AND METHODS RELATED TO THE PRODUCTION OF ETHYLENE OXIDE, ETHYLENE GLYCOL, AND/OR ETHANOLAMINES
Disclosed herein is a method comprising the steps of: a) producing a hydrocarbon stream from syngas via a Fischer-Tropsch reaction, wherein the hydrocarbon...
2018/0044307 NOVEL PROCESS FOR THE PREPARATION OF RANOLAZINE
A process for the preparation of Ranolazine (I) and its acid addition salts and the process for the preparation of compound of formula (7). ##STR00001##
2018/0044306 1,3,4-THIADIAZOL-2-YL-BENZAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY
The present invention relates to inhibitors of the Wnt signalling pathways of general formula (I) as described and defined herein, to methods of preparing said...
2018/0044305 3-SUBSTITUTED 1,3,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS
The present invention relates to 3-substituted 1,3,4-oxadiazole and thiadiazole compounds of formula (I) and their use to inhibit the programmed cell death 1...
2018/0044303 1,2,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS
The present invention relates to 1,2,4-oxadiazole compounds of formula (I) and their use to inhibit the programmed cell death 1 (PD-1) signaling pathway and/or...
2018/0044302 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES
Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and...
2018/0044301 TRIAZINE-CONTAINING PHOTOCURABLE RESIN AND PREPARATION METHOD THEREOF
The present invention discloses a triazine-containing photocurable resin and a preparation method thereof. The preparation method of the resin comprises the...
2018/0044300 AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of...
2018/0044299 SYNTHESIS OF CYCLOCREATINE AND ANALOGS THEREOF
Provided herein is a process an intermediates for the preparation of a compound of formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof, using...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.